PPCB
What one share of Propanc Biopharma holds
Pharmaceutical Preparations
Propanc Biopharma’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$17.62 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$5.06 |
| Cash and investments | $0.25 |
| Debt | $0.02 |
| Book value | $2.84 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | — | −$56.06 | — | −$14.61 | — | −$29.87 |
| 2019 | — | −$274.24 | $0.14 | −$98.25 | — | −$111.09 |
| 2021 | — | −$19.93 | — | −$9.44 | — | — |
| 2023 | — | −$44.96 | — | −$15.89 | — | — |
| 2025 | — | −$371.22 | — | −$2.55 | — | — |
| 2026 | — | −$17.62 | $0.00 | −$5.06 | — | $2.84 |